Is testosterone replacement therapy appropriate for patients with prostate cancer who have persistently low testosterone and associated symptoms, without signs of recurrence, and have a Gleason score of 4+4, treated with radiation and completed andro
No direct evidence for testosterone replacement therapy in high-risk prostate cancer survivors post-radiotherapy and ADT was found; limited indirect evidence suggests cautious consideration may be possible in some cases, with regular monitoring.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24375582
- Primary Topic
- Hormonal and reproductive studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00